Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo-2
DRUG
2 trials
Sponsors
GlaxoSmithKline
, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions
Aging
Pulmonary Disease, Chronic Obstructive
Phase 1
Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients
Terminated
NCT03243760
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
Start: 2016-02-10
End: 2016-08-20
Updated: 2020-06-30
Unknown Phase
Anti-age Dietary Supplements in Healthy Older Adults: the proBNPage Reduction Trial
NCT05500742
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Aging
Start: 2022-07-22
End: 2024-11-30
Updated: 2023-02-02
Related Papers
Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 "Anti-Aging" Food Supplements in Healthy Older Adults).
2023-10-27
1 citations
A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study.
2020-04-21
16 citations